BRAF and cancer: In general, FV-PTCs are clinically indolent RAS-driven tumors, while TCV-PTCs are BRAF-driven cancers with poor prognosis, and therefore no apparent genetic association exist – even though the FV-PTC in our case was BRAF mutated, which is unusual but not entirely uncommon.[13]